Sonnet BioTherapeutics Holdings, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q2 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Sonnet BioTherapeutics Holdings, Inc. annual/quarterly Operating Lease, Payments history and growth rate from Q1 2019 to Q2 2022.
  • Sonnet BioTherapeutics Holdings, Inc. Operating Lease, Payments for the quarter ending June 30, 2022 was $24.7K, a 3.31% decline year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Operating Lease, Payments for 2024 was $93.6K, a 18.1% increase from 2023.
  • Sonnet BioTherapeutics Holdings, Inc. annual Operating Lease, Payments for 2023 was $79.3K, a 19.2% decline from 2022.
  • Sonnet BioTherapeutics Holdings, Inc. annual Operating Lease, Payments for 2022 was $98.1K, a 3.36% decline from 2021.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2022 $24.7K -$845 -3.31% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q2 2021 $25.5K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q4 2020 $25.1K Oct 1, 2020 Dec 31, 2020 10-Q 2021-02-16
Q1 2019 $988K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.